Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
J Clin Monit Comput ; 36(5): 1441-1448, 2022 10.
Article in English | MEDLINE | ID: mdl-34877626

ABSTRACT

Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate FiO2. Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on the reliability of HFO devices at these high [Formula: see text] are available. We sought to evaluate factors affecting oxygenation while using HFO systems at high [Formula: see text] in a bench study. Spontaneous breathing was generated with a mechanical test lung connected to a mechanical ventilator Servo-i®, set to volume control mode. Gas flow from a HFO device was delivered to the test lung. The influence on effective inspired oxygen fraction of three parameters (FiO2 0.6, 0.8, and 1, [Formula: see text] from 28 to 98.1 L/min, and HFO Gas Flows from 40 to 60 L/min) were analyzed and are reported. The present bench study demonstrates that during HFO treatment, measured FiO2 in the lung does not equal set FiO2 on the device. The substance of this variation (ΔFiO2) is tightly correlated to [Formula: see text] (Pearson's coefficient of 0.94, p-value < 0.001). Additionally, set FiO2 and Flow at HFO device appear to significatively affect ΔFiO2 as well (p-values < 0.001, adjusted to [Formula: see text] ). The result of multivariate linear regression indicates predictors ([Formula: see text] , Flow and set FiO2) to explain 92% of the variance of delta FiO2 through K-Fold Cross Validation. Moreover, adjunction of a dead space in the breathing circuit significantly decreased ΔFiO2 (p < 0.01). The present bench study did expose a weakness of HFO devices in reliability of delivering accurate FIO2 at high [Formula: see text] as well as, to a lesser extent, at [Formula: see text] below equivalent set HFO Flows. Moreover, set HFO flow and set FIO2 did influence the variability of effective inspired oxygen fraction. The adjunction of a dead space in the experimental set-up significantly amended this variability and should thus be further studied in order to improve success rate of HFO therapy.


Subject(s)
Cannula , Respiratory Insufficiency , Adult , Humans , Oxygen , Oxygen Inhalation Therapy , Reproducibility of Results , Respiratory Insufficiency/therapy
2.
J Infect Chemother ; 25(8): 589-593, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31005566

ABSTRACT

OBJECTIVES: Deep sampling (DS) is the gold standard for microbiological diagnosis of post-sternotomy mediastinitis (PSM), however superficial swab (SS) are frequently performed in some centers and antibiotherapy initiated base on their results. We analysed the concordance between superficial swab and deep sampling in PSM. MATERIALS AND METHODS: We analysed retrospectively patients with a PSM between 2010 and 2014 at Saint-Luc University hospital (Belgium). We considered that there was a concordance between SS and DS when the same microorganism was found in the two sampling method in each patient. Patients were stratified in six groups according to microbiology results as Staphylococcus Aureus (SA) sensitive or resistant, coagulase negative Staphylococcus (CoNS), Gram negative bacilli (GNB), other Gram positive bacteria (GPB) and fungi. RESULTS: Thirty-six patients were included. Twenty-five men (69%) and a mean age of 66 years old. The overall concordance between SS and DS was 57%. SA and GNB showed high concordance (100% and 85.7% respectively). For the other groups the concordance was low. The sensitivity and specificity of SS was 97% and 33% respectively. The PPV and NPV of superficial swab was 96% and 50% respectively. CONCLUSION: Microbiological results from SS, even with flocked swabs, except for SA and GNB have low concordance with those obtained from deep sampling. Our data confirm that in PSM, deep sampling is the gold standard for microbiological assessment.


Subject(s)
Mediastinitis/diagnosis , Mediastinitis/microbiology , Staphylococcal Infections/diagnosis , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Aged , Female , Humans , Male , Retrospective Studies , Specimen Handling/methods , Sternotomy/methods , Surgical Wound Infection/diagnosis , Surgical Wound Infection/microbiology
3.
Indian J Otolaryngol Head Neck Surg ; 76(3): 2361-2366, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38883452

ABSTRACT

Aims: The oropharyngeal dysphagia (OD) poses substantial health risks and affects quality of life. Patient-reported outcome measures (PROMs) are gaining prominence for their crucial role in early detection and adapting rehabilitation and management decisions. This highlights the need for culturally pertinent versions in different languages, especially when addressing conditions like OD. This study aimed to translate, culturally adapt, and assess the test-retest reliability of the Sydney Swallow Questionnaire (SSQ), a PROM designed to detect the risk of OD, for Dutch-speaking populations. Materials and Methods: The SSQ was translated and adapted based on Beaton's guidelines. Validity and test-retest reliability were assessed in 100 healthy participants, with a subset of 30 participants assessed over a 15-day interval. Intra-class correlation coefficient (ICC) values were calculated to determine test-retest reliability. Results: The SSQ-Dutch was well received and well understood, with a median total score of 65.5/1700. Notably, 95% of participants scored below the established dysphagia risk cut-off, consistent with previous validations. The 15-day interval ICC for the SSQ-Dutch total scores was 0.82 (CI 95%: 0.66-0.91), indicating good reliability. While most questions had moderate-to-good reliability, five showed slightly lower ICC. Conclusion: The SSQ-Dutch emerges as a validated and reliable tool for assessing OD risk in Dutch-speaking individuals. Future studies should evaluate its efficacy in symptomatic populations and consider cultural variations in Dutch-speaking regions. Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-024-04484-3.

4.
Rev Mal Respir ; 2024 Jun 25.
Article in French | MEDLINE | ID: mdl-38926024

ABSTRACT

INTRODUCTION: Chest-physiotherapy is a key element in treatment of cystic fibrosis and patient adherence is a major issue in global cystic fibrosis care. This study aims to assess adherence to chest physiotherapy in adults with cystic fibrosis who not treated with tritherapy and to analyze the impact of certain factors on adherence. METHODS: Thus is a cross-sectional study, conducted using a questionnaire and a physiotherapy evaluation. Adherence to this treatment was measured in terms of quantitative and qualitative aspects. The impact on adherence of 15 factors was then assessed. RESULTS: Only 47% of patients could be considered as adherent, with a significant disparity between a quantitative and qualitative assessment. Gender, working time, pathology severity, the fact of being regularly followed by a physiotherapist, the perceived benefit of the sessions and their replacement by physical activity, seem associated with adherence to this treatment. CONCLUSIONS: Taking into account the qualitative aspect of the sessions, our study reveals a low rate, in our cohort, of adherence to respiratory physiotherapy, and highlights six factors likely to predominate. Regular follow-up by a physiotherapist seems to be a determining factor in adherence to this treatment.

5.
Rev Mal Respir ; 40(5): 432-452, 2023 May.
Article in French | MEDLINE | ID: mdl-37080877

ABSTRACT

Patients with chronic cough experience major alteration in their quality of life. Given its numerous etiologies and treatments, this disease is a complex entity. To help clinicians involved in patient management of patients, guidelines have been issued by a group of French experts. They address definitions of chronic cough and initial management of patients with this pathology. We present herein the second-line tests that might be considered in patients whose coughing has persisted, notwithstanding initial management. The experts have also put forward a definition of unexplained or refractory chronic cough (URCC), the objective being to more precisely identify those patients whose cough persists despite optimal management. Lastly, these guidelines indicate the pharmacological and non-pharmacological interventions of use in URCC. Amitriptyline, pregabalin, gabapentin or morphine combined with speech and/or physical therapy are mainstays in treatment strategies. Other treatment options, such as P2X3 antagonists, are being developed and have generated high hopes among physicians and patients alike.


Subject(s)
Cough , Quality of Life , Humans , Adult , Cough/diagnosis , Cough/etiology , Cough/therapy , Chronic Disease , Gabapentin/therapeutic use , Amitriptyline/therapeutic use
6.
Eur Respir J ; 37(1): 72-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20562123

ABSTRACT

Sildenafil and vardenafil, two selective inhibitors of phosphodiesterase type 5 (PDE5) are able, when applied by intraperitoneal injection, to activate chloride transport in cystic fibrosis (CF) mice homozygous for the F508del mutation. Oral treatment with the drugs may be associated with adverse haemodynamic effects. We hypothesised that inhaled PDE5 inhibitors are able to restore ion transport in F508del CF airway epithelium. We developed a restraint-free mouse chamber for inhalation studies. PDE5 inhibitors were nebulised for 15 min at concentrations adjusted from recommended therapeutic oral doses for male erectile dysfunction. We measured in vivo nasal transepithelial potential difference 1 h after a single inhalation of sildenafil, vardenafil or tadalafil in F508del CF and normal homozygous mice. After nebulisation with the drugs in F508del mice, chloride transport, evaluated by perfusing the nasal mucosa with chloride-free buffer containing amiloride followed by forskolin, was normalised; the forskolin response was increased, with the largest values being observed with tadalafil and intermediate values with vardenafil. No detectable effect was observed on sodium conductance. Our results confirm the role of PDE5 inhibitors in restoring chloride transport function of F508del CF transmembrane conductance regulator protein and highlight the potential of inhaled sildenafil, vardenafil and tadalafil as a therapy for CF.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Phosphodiesterase 5 Inhibitors/administration & dosage , Administration, Inhalation , Animals , Chlorides/metabolism , Cystic Fibrosis/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Homozygote , Humans , Imidazoles/administration & dosage , Mice , Mice, Transgenic , Nebulizers and Vaporizers , Phosphoric Diester Hydrolases/metabolism , Piperazines/administration & dosage , Purines/administration & dosage , Sildenafil Citrate , Sulfones/administration & dosage , Time Factors , Triazines/administration & dosage , Vardenafil Dihydrochloride
7.
Respir Med Res ; 80: 100833, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34147867

ABSTRACT

BACKGROUND: Field tests are useful to assess the functional exercise capacity. The 6minute walking test (6MWT) is the most common field test even if alternatives are needed. The main aim of the study was to verify if the 3minute step test (3MST) is a valid tool to measure the functional exercise capacity and can surrogate the 6MWT in healthy children from 6- to 12-years-old. METHODS: This randomized cross-over trial recruited 30 healthy children from 6 to 12 years. One 6MWT and two 3MST (3MST1 and 3MST2) were performed randomly on 3 consecutive days. The variables were the distance (6MWT), the number of steps (3MST) and the cardiorespiratory parameters. RESULTS: The distance walked during 6MWT was very strongly correlated to the number of steps during the 3MST (3MST1: rho=0.833; P<0.001 and 3MST2: rho=0.868; P<0.001). Heart rate (HR) was lower than the theoretical maximal HR at the end of both tests. The change in HR and perceived fatigue were significantly higher after the 3MST. A learning effect was observed in the 3MST (+8 steps; P<0.001). CONCLUSIONS: The 3MST is validated and can be a surrogate for the 6MWT in healthy children population between 6 and 12 years old. A training test is required in these children.


Subject(s)
Exercise Test , Exercise Tolerance , Child , Humans , Reproducibility of Results , Walk Test , Walking
8.
Rev Mal Respir ; 38(6): 646-663, 2021 Jun.
Article in French | MEDLINE | ID: mdl-33895033

ABSTRACT

Chronic respiratory disease is a major cause of morbidity and mortality worldwide and an important cause of disability including a reduction of exercise, functional and muscle capacity contributing to a decreased quality of life. In the context of pulmonary rehabilitation, a thorough patient-centered outcome assessment, including not only measures of lung function, but also exercise functional and muscle capacity, is imperative for a comprehensive disease management. Assessment of these impairments and dysfunctions with appropriate and change-sensitive procedures is thus necessary for personalizing the physical interventions and assessing the short- and long-term effectiveness of the intervention. The clinician currently has a wide variety of tests and measurements available to assess the physical and functional capacity of people with chronic respiratory disease. The aim of this review is to provide a pragmatic synthesis of the physical, functional and muscle capacity tests most commonly used in pulmonary rehabilitation. Ultimately, it should help the clinician to identify the relevant evaluations according to the objectives of the patients but also according to the available resources, the setting of pulmonary rehabilitation and the specific qualities of each test.


Subject(s)
Pulmonary Disease, Chronic Obstructive , Quality of Life , Exercise , Exercise Tolerance , Humans , Pulmonary Disease, Chronic Obstructive/diagnosis
9.
Rev Mal Respir ; 38(2): 171-176, 2021 Feb.
Article in French | MEDLINE | ID: mdl-33288396

ABSTRACT

Nebulization is a drug delivery mode whose prescription and application remain uncertain. A guide to good practice has been proposed by the work group on aerosol therapy of the French Society for Respiratory Diseases, so-called GAT. The previous recommendations date from 2007. In addition to an update of data on nebulization, these expert recommendations aim to be of real help to the prescriber.


Subject(s)
Drug Delivery Systems , Nebulizers and Vaporizers , Administration, Inhalation , Aerosols , Humans
10.
Respir Med Res ; 78: 100777, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32623309

ABSTRACT

BACKGROUND: Clinical tools for assessment of the skeletal muscle strength are scarce and have rarely been validated in children. The aims of this study were to verify the construct validity of the one-minute sit-to-stand test (1-MSTST) to evaluate the quadriceps strength in healthy children between 12 and 18 years old and to correlate these outcomes with the anthropometric parameters. METHODS: Healthy children were recruited and consecutively performed 1-MSTST and maximal voluntary contraction of the quadriceps (QMVC). RESULTS: Eighty-three children (15±2 years old) were analyzed. Contrarily to the QMVC, neither the number of 1-MSTST repetitions nor the sit-to-stand work (1-MSTST expressed as the product of body weight) differed between genders. The QMVC was not correlated with the number of repetitions (rho=-0.056; P=0.617) but correlated with 1-MSTST when expressed as a product of body weight (r=0.491; P<0.001). The QMVC was also correlated with age (r=0.314; P=0.004), height (r=0.672; P<0.001), weight (r=0.721; P<0.001) and BMI (r=0.451; P<0.001) whereas 1-MSTST did not correlate with any of these parameters. The leg length was related to the results of both tests. CONCLUSION: We demonstrated that the one-minute sit-to-stand test can be considered as a valid and valuable alternative to evaluate the muscle strength when expressed as the product of body weight.


Subject(s)
Exercise Test/methods , Muscle Strength/physiology , Quadriceps Muscle/physiology , Adolescent , Belgium , Child , Exercise Tolerance/physiology , Feasibility Studies , Female , Humans , Male , Posture/physiology , Sitting Position , Standing Position , Time Factors
11.
Respir Med Res ; 75: 13-25, 2019 May.
Article in English | MEDLINE | ID: mdl-31235453

ABSTRACT

INTRODUCTION: The aim of this systematic review was to summarize the effects of yoga, qi gong or tai chi in COPD patients. METHODS: Studies evaluating effects of the selected complementary therapies on lung function, dyspnea, quality of life or functional exercise capacity in COPD patients were identified and reviewed from three databases. RESULTS: Eighteen studies were included. Six studies evaluated the effects of yoga and the others focused on tai chi or qi gong separately or combined. The duration of the programs ranged from 6 weeks to 6 months and the frequency from 2 to 7 times a week. Each session reached 30 to 90 minutes. Benefits were observed on lung function and functional exercise capacity but benefit was clearly stated neither on quality of life nor on dyspnea. CONCLUSION: This systematic review highlights the potential of these therapies as complementary therapeutic approach in COPD patients.


Subject(s)
Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/therapy , Qigong , Tai Ji , Yoga , Adult , Aged , Aged, 80 and over , Complementary Therapies , Dyspnea/epidemiology , Dyspnea/etiology , Dyspnea/therapy , Female , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/epidemiology , Quality of Life , Treatment Outcome
12.
Rev Mal Respir ; 35(3): 264-268, 2018 Mar.
Article in French | MEDLINE | ID: mdl-29395560

ABSTRACT

INTRODUCTION: Six minutes walking test (6MWT) is regularly used in pulmonology. To minimize the risk of cross-infection, some patients must wear surgical mask at rest and sometimes during exercise. AIM OF THE STUDY: To evaluate the effect of wearing a surgical mask during 6MWT in healthy subjects. MATERIAL AND METHOD: It is a prospective study on 44 healthy subjects. After a first 6MWT for training, they performed randomly two 6MWT: with or without a surgical mask. Distance and dyspnea, heart rate and saturation variations were recorded. RESULTS: Distance was not modified by the mask (P=0.99). Dyspnea variation was significantly higher with surgical mask (+5.6 vs. +4.6; P<0.001) and the difference was clinically relevant. No difference was found for the variation of other parameters. CONCLUSION: Wearing a surgical mask modifies significantly and clinically dyspnea without influencing walked distance.


Subject(s)
Dyspnea/etiology , Masks/adverse effects , Surgical Attire/adverse effects , Walking/physiology , Adolescent , Adult , Dyspnea/epidemiology , Dyspnea/physiopathology , Exercise Test , Female , Heart Rate/physiology , Humans , Male , Respiration , Young Adult
13.
J Cyst Fibros ; 6(3): 187-93, 2007 May.
Article in English | MEDLINE | ID: mdl-17027346

ABSTRACT

It has recently been stated that a database is an essential tool in the management of CF. The purpose of this work is to create a specific database allowing optimal performance of storage, search and retrieval functions on patients with CF. A specific database was developed using a Windev licence, for application via Microsoft supported platforms or Intranet system. The database allows real-time point of care data management of medical, investigational and administrative data. It is currently being used in the 6 Belgian reference centres. It represents a useful tool for gathering information on routine clinical and lab data, bacteriology, treatments, complications and specific outcomes for clinical and research purposes. The ongoing evolution of the database includes enhancements toward research data orientation including comparison of patient data between different centres and completeness of the National CF registry questionnaire. A complimentary copy of the software can be provided to multidisciplinary accredited CF centres worldwide upon request.


Subject(s)
Cystic Fibrosis , Database Management Systems , Databases, Factual , Registries , Belgium/epidemiology , Cystic Fibrosis/complications , Cystic Fibrosis/epidemiology , Cystic Fibrosis/therapy , Humans , Information Storage and Retrieval
14.
Rev Mal Respir ; 24(10): 1351-61, 2007 Dec.
Article in French | MEDLINE | ID: mdl-18216754

ABSTRACT

INTRODUCTION: Nebulization may transport with the drug some small particles containing microbes. STATE OF THE ART: These microbes may be present in all parts of the nebulizer, including the drug solution itself. Depending on the studies, contamination of the nebulizers may reach up to 55% of the devices in patients with cystic fibrosis. That's why using one nebulizer for one patient, using drug sterile ampoules, and having a good hygiene during and after the nebulization are so important. The national disinfection recommendations, usually depending on the type of the nebulizer, are variable from one to another country and are not very well validated. Moreover, the repetitive use of these disinfection techniques on the performances of the nebulizer are neither studied. In daily life, the patients respect these disinfection recommendations in 3 to 98% of the cases. PERSPECTIVES: We propose a standardized methodology for evaluating the microbial and functional effects of all disinfectants on the nebulizers. CONCLUSION: A simple, quick, efficacious, cheap, and without effect on nebulizer performances disinfectant is still waiting.


Subject(s)
Disinfection , Equipment Contamination/prevention & control , Nebulizers and Vaporizers/microbiology , Cystic Fibrosis/drug therapy , Humans , Infection Control
15.
Rev Mal Respir ; 24(8): 1013-23, 2007 Oct.
Article in French | MEDLINE | ID: mdl-18033188

ABSTRACT

INTRODUCTION: Aerosols, these particles considered initially like "magic", are slowly delivering their secrets. STATE OF ART: For several years studies on the subject have increased and companies have maximised their efforts to improve the technology for transforming drugs into the optimal aerosol. Recently new systems have appeared on the market. Mesh nebulisers can reduce the inhalation time, metered dose inhalers have modified their formulations to improve the efficiency of drug deposition and dry powder inhalers require lower inspiratory flows. PERSPECTIVES/CONCLUSIONS: In the near future new systems using technologies of greater or lesser sophistication should appear on the market.


Subject(s)
Lung Diseases/drug therapy , Nebulizers and Vaporizers , Administration, Inhalation , Equipment Design , Humans , Powders , Technology, Pharmaceutical
17.
Rev Mal Respir ; 34(4): 282-322, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28552256

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of chronic respiratory failure and extra-respiratory systemic organ disorders. The previous French Language Respiratory Society (SPLF) guidelines on COPD exacerbations were published in 2003. Using the GRADE methodology, the present document reviews the current knowledge on COPD exacerbation through 4 specific outlines: (1) epidemiology, (2) clinical evaluation, (3) therapeutic management and (4) prevention. Specific aspects of outpatients and inpatients care are discussed, especially regarding assessment of exacerbation severity and pharmacological approach.


Subject(s)
Pulmonary Disease, Chronic Obstructive/therapy , Acute-Phase Reaction , Disease Progression , France , Humans , Language , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/pathology , Quality of Life , Severity of Illness Index , Societies, Medical/standards , Survival Analysis
18.
J Aerosol Med ; 19(2): 199-207, 2006.
Article in English | MEDLINE | ID: mdl-16796544

ABSTRACT

The intrapulmonary percussive ventilation (IPV), frequently coupled with a nebulizer, is increasingly used as a physiotherapy technique; however, its physiologic and clinical values have been poorly studied. The aim of this study was to compare lung deposition of amikacin by the nebulizer of the IPV device (Percussionaire; Percussionaire Corporation; Sandpoint, ID) and that of standard jet nebulization (SST; SideStream; Medic-Aid; West Sussex, UK). Amikacin was nebulized with both devices in a group of five healthy subjects during spontaneous breathing. The deposition of amikacin was measured by urinary monitoring. Drug output of both devices was measured. Respiratory frequency (RF) was significantly lower when comparing the IPV device with SST (8.2 +/- 1.6 breaths/min vs. 12.6 +/- 2.5 breaths/min, p < 0.05). The total daily amount of amikacin excreted in the urine was significantly lower with IPV than with SST (0.8% initial dose vs. 5.6% initial dose, p < 0.001). Elimination halflife was identical with both devices. Drug output was lower with IPV than with SST. The amount of amikacin delivered to the lung is sixfold lower with IPV than with SST, although a lower respiratory frequency was adopted by the subjects with the IPV. Therefore, the IPV seems unfavorable for the nebulization of antibiotics.


Subject(s)
Amikacin/administration & dosage , Amikacin/pharmacokinetics , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacokinetics , Lung/physiology , Administration, Inhalation , Adult , Amikacin/urine , Anti-Bacterial Agents/urine , Humans , Male , Monitoring, Physiologic , Nebulizers and Vaporizers , Particle Size , Pulmonary Ventilation , Spirometry , Ventilators, Mechanical
19.
Rev Mal Respir ; 23(6): 599-606, 2006 Dec.
Article in French | MEDLINE | ID: mdl-17202965

ABSTRACT

INTRODUCTION: Respiratory infections play a deleterious role in the progression of patients suffering from cystic fibrosis. Cross infections and epidemics have been documented in these patients, justifying a rigorous prevention regime. BACKGROUND: This prevention regime concerns all health workers and rests on various recommendations. Segregation of patients and hand hygiene are important factors. Respiratory equipment and, more specifically, nebulisers represent a potential source of bacterial contamination requiring special attention. In the same perspective the risks related to the health care environment, particularly the lung function laboratory, should not be ignored. The modalities of prevention sometimes have a significant psychological impact that may often be reduced by careful explanation. CONCLUSIONS: In view of the time spent in contact with these patients the physiotherapists are naturally involved in this prevention regime which is an integral part of their treatment.


Subject(s)
Cross Infection/prevention & control , Cystic Fibrosis/rehabilitation , Physical Therapy Modalities/adverse effects , Physical Therapy Modalities/instrumentation , Respiratory Tract Infections/prevention & control , Breathing Exercises/adverse effects , Cystic Fibrosis/complications , Cystic Fibrosis/microbiology , Disinfectants , Equipment Contamination , Hand Disinfection , Humans , Nebulizers and Vaporizers , Respiratory Tract Infections/etiology , Respiratory Tract Infections/microbiology
20.
Rev Mal Respir ; 33(7): 573-82, 2016 Sep.
Article in French | MEDLINE | ID: mdl-27209116

ABSTRACT

INTRODUCTION: Beneficial effects of physical exercise have been previously demonstrated in patients with chronic obstructive pulmonary disease. The aim of this systematic review was to summarize the evidence supporting physical exercise to improve on lung function, exercise capacity and quality of life in cystic fibrosis patients. METHODS: Medline database was used to search clinical studies from 2000 to 2015. We also analyzed the bibliographic section of the included studies, in order to identify additional references. RESULTS: A total of 17 studies were identified. A great disparity was found in the results of the different studies. No systematic benefit was found on lung function, exercise capacity or quality of life. No relationship between the type of program and the benefits achieved was observed. CONCLUSIONS: Evidence that physical exercise benefits lung function, exercise capacity and quality of life in cystic fibrosis patient is inconsistent and evidence does not support a particular standardized program for all patients.


Subject(s)
Cystic Fibrosis/therapy , Exercise/physiology , Cystic Fibrosis/physiopathology , Exercise Tolerance/physiology , Humans , Maximal Respiratory Pressures , Quality of Life , Respiration
SELECTION OF CITATIONS
SEARCH DETAIL